Martin Béhé

Radiometal-Labelled Macrocyclic Chelator-Derivatised Somatostatin Analogue with Superb Tumour-Targeting Properties and Potential for Receptor-Mediated Internal Radiotherapy

A. Heppeler, Sylvie Froidevaux, Helmut R. Mäcke et al. · Chemistry - A European Journal · 1999 · 332 citations

Peptide Engineering, Peptide Science, Peptide Therapeutics +18

Yttrium-90 DOTATOC: first clinical results

Andreas Otte, R. Herrmann, A. Heppeler et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1999 · 323 citations

Medicine, Clinical Evidence, Yttrium-90 Dotatoc +1

High-resolution SPECT using multipinhole collimation

N. Schramm, G. Ebel, U. Engeland et al. · IEEE Transactions on Nuclear Science · 2003 · 298 citations

Computed Tomography, Positron Emission Tomography, Tissue Imaging +15

DOTATOC: A powerful new tool for receptor-mediated radionuclide therapy

Andreas Otte, E. Jermann, Martin Béhé et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1997 · 214 citations

Engineering, Novel Therapy, Powerful New Tool +9

Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy

Marion de Jong, Willem H. Bakker, Eric P. Krenning et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1997 · 212 citations

Promising Somatostatin Analogue, Engineering, Indium-111 Labelling +10